Aptamer 学术简报 — therapeutic — 2026-11-10

自动生成 by RBTX Aptamer Tracker v0.1。 子主题 therapeutic:近 14 天 68 篇命中(aptamer 池 196 篇)。

评分公式:composite = 0.45×log(IF) + 0.35×log(cites_velocity) + 0.10×social + 0.10×recency_bonus;满分 100。


#1 [28.4] abcFISH enables multiplexed, single-molecule visualization of circular RNA spatial heterogeneity.

Understanding the subcellular localization of RNAs is critical for their functions, but visualizing circular RNAs (circRNAs) has been hindered by their sequence overlap with linear counterparts. Here we developed amplicon-based circRNA fluorescence in situ hybridization (abcFISH), which uses an optimized rolling-circle amplification strategy tar...


#2 [13.0] Smart dual-ligand-functionalized magnetic nanocomposites for rapid disruption of EpCAM-positive extracellular vesicles.

BACKGROUND: Epithelial Cell Adhesion Molecule positive (EpCAM+) extracellular vesicles (EVs) can promote cancer progression and metastasis. Thus, it is necessary to develop targeted strategies to disable EpCAM+ EVs. RESULTS: In this work, inspired by the ability of antiviral curvature-sensing peptides to disrupt highly curved lipid membranes (<3...


#3 [13.0] Dual-aptamer-activated RCA-MOF synergistic platform for visual detection of leukemia-derived exosomes.

The sensitive, point-of-care detection of acute myeloid leukemia (AML)-derived exosomes is essential for non-invasive diagnosis and therapy monitoring, but remains technically challenging. Here we report a colorimetric biosensor based on a dual -aptamer-initiated catalytic cascade, where simultaneous recognition of exosomal markers CD63 and PTK7...


#4 [12.8] CRISPR-enabled ultrasensitive surface-enhanced Raman scattering sensing platform for background-free detection of phosphorylated tau in Alzheimer's disease.

Accurate and ultrasensitive detection of phosphorylated tau at threonine 231 (P-tau231), a pathologically validated early biomarker of Alzheimer's disease (AD), is essential for preclinical diagnosis and longitudinal monitoring. However, blood-based detection remains challenging because of the femtomolar physiological abundance, substantial inte...


#5 [12.7] Aptamer-mediated multivalent endogenous ADAR1 recruitment for highly efficient RNA editing.

Adenosine-to-inosine RNA editing mediated by endogenous ADAR enzymes represents a promising therapeutic strategy because it can correct mutations at the transcript level without inducing permanent changes to the genome. However, existing systems face challenges, particularly the limited editing efficiency, which limits their practical applicatio...


#6 [12.5] Use of a c-Met-targeting aptamer-drug conjugate for efficient therapy in both primary and metastatic uveal melanoma.

Uveal melanoma (UM), the most common primary intraocular malignancy in adults, is associated with a high risk of metastasis, recurrence, and irreversible vision loss. However, current therapeutic options remain limited by insufficient efficacy and poor vision preservation. Building upon the molecular design of SL1-MMAE, a c-Met-targeting aptamer...


#7 [11.7] From recognition to delivery: nucleic acid aptamers in miRNA-related diagnosis and therapy of hepatocellular carcinoma

Hepatocellular carcinoma (HCC), the most common primary malignant liver tumour, remains a major clinical challenge because of its low early diagnosis rate and high post-treatment recurrence. MicroRNAs (miRNAs) play key regulatory roles in HCC development and progression and are potential liquid biopsy biomarkers and therapeutic targets. However,...


#8 [11.6] Aptamer-modified magnetic chitosan nanocomposites for rapid and targeted decontamination of aflatoxin B(1) in medicine-food homologous decoctions.

A novel aptamer-functionalized core-shell magnetic chitosan adsorbent (Fe₃O₄@CS@apt) was developed for the selective removal of a flatoxin B1 (AFB1). The material was synthesized via emulsification cross-linking followed by EDC/sulfo-NHS-mediated aptamer conjugation. Characterization confirmed the core-shell structure and superparamagnetic prope...


#9 [11.1] Expanding synthetic lethality through computationally designed aptamers

Aptamers are emerging as versatile tools in cancer research and therapy because they combine high target specificity with low immunogenicity, chemical tractability, and straightforward sequence optimization. They have been developed for tumor recognition, biomarker detection, targeted delivery of drugs and therapeutic RNAs, and direct modulation...


#10 [11.0] NIR-II-Accelerated 2D-on-2D Silicene/MOF Heterointerfaces Disrupt Tumor Redox Homeostasis for Targeted Ferroptosis.

Catalytic ferroptosis therapy provides an attractive approach for tumor treatment, but its practical efficacy is often limited by insufficient reaction kinetics and the strong redox buffering capacity of the tumor microenvironment. Herein, we report an interface-engineered 2D-on-2D catalytic nanoplatform, SNs/FTC@Apt-P (SFTCP), constructed by in...



Methodology